Analysis of 2023 World Health Organization cancer Essential Medicines List and concordance with resource-stratified guidelines.

ABSTRACT:

Background

The World Health Organization (WHO) Essential Medicines List (EML) and resource-stratified guidelines both prioritize high-value medicines. We compared the 2023 EML cancer medicines list with global cancer statistics, examined the proportion of EML therapies recommended by resource-stratified guidelines, and identified gaps that merit evaluation by the WHO EML Committee.

Methods

We compared the 2023 EML medicines for adult cancers with cancer incidence and mortality data from GLOBOCAN 2022. We cross-referenced the EML with 2 resource-stratified guidelines (National Comprehensive Cancer Network [NCCN] and National Cancer Grid [NCG] of India) and evaluated preferred treatments in resource-stratified guidelines that were not recommended by the EML.

Results

The

SUBMITTER: Wilson BE 

PROVIDER: S-EPMC12505124 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature